Tapewire

NYSE · USD

ICE

Intercontinental Exchange, Inc.

Export transactions ↓
Tapewire entity
1809
SEC CIK
0001571949
Parsed reports
941

Last 12 months

Inside the activity.

0 purchase rows · 64 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202505
Jan 202600
Feb 2026026
Mar 202601
Apr 202600
May 202606
Jun 202602
Jul 202604
Aug 2026010
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 300 $114.63 $34,388.01
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 7

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · CPEX

Disclosed balance after: 2,881,705

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F9 · price: The price range for the aggregate amount sold by the direct holder is $114.46 - $114.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F10 · balance_after: As previously reported, the reporting person also indirectly owns 2,881,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 3,800 $113.76 $432,295.60
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 6

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · CPEX

Disclosed balance after: 2,882,005

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F8 · price: The price range for the aggregate amount sold by the direct holder is $113.39 - $114.29. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 25,900 $112.63 $2,917,158.44
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 5

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · CPEX

Disclosed balance after: 2,885,805

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F7 · price: The price range for the aggregate amount sold by the direct holder is $112.39 - $113.37. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 600 $114.67 $68,799.00
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 4

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,169,965

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F5 · price: The price range for the aggregate amount sold by the direct holder is $114.44 - $114.71. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,128,580 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 12,262 $113.78 $1,395,145.84
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 3

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,170,565

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F4 · price: The price range for the aggregate amount sold by the direct holder is $113.37 - $114.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 75,821 $112.65 $8,540,962.69
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,182,827

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F3 · price: The price range for the aggregate amount sold by the direct holder is $112.37 - $113.36. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
September 21, 2023 Filed Sep 25, 2023 16:43 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 70,442 $41.59 $2,929,682.78
Disclosure

SEC source: 0001209191-23-050484 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,258,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 9, 2022.

F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 20:31 UTC
Williams Stuart GlenChief Operating Officer
Tax withholdingCommon Stock 764 $115.72 $88,410.08
Disclosure

SEC source: 0001209191-23-049961 · doc4.xml · nonDerivative · entry 1

Williams Stuart Glen · CIK 0001942706 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,094

F1 · shares: Represents shares of restricted stock units issued to the filing person on September 15, 2022. The restricted stock units vest over three years (1/3 on September 15, 2023, 1/3 on September 15, 2024 and 1/3 on September 15, 2025). Of the 5,081 shares, 1,693 shares were issued on September 15, 2023, of which 764 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 3,388 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 3,575 shares of common stock and 3,388 unvested restricted stock units ("RSUs"), and 3,131 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 20:32 UTC Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 2,000 $0.00 Strike: $41.37 $0.00
Disclosure

SEC source: 0001209191-23-049771 · doc4.xml · derivative · entry 3

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,100

Underlying: Common Stock · 2,000 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 20:32 UTC SaleCommon Stock 2,000 $117.14 $234,280.00
Disclosure

SEC source: 0001209191-23-049771 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,647

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 112,373 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 20:32 UTC Exercise / conversionCommon Stock 2,000 $41.37 $82,740.00
Disclosure

SEC source: 0001209191-23-049771 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.

Read SEC document
September 11, 2023 Filed Sep 13, 2023 20:32 UTC
Edmonds Christopher ScottChief Development Officer
SaleCommon Stock 1,427 $115.00 $164,105.00
Disclosure

SEC source: 0001209191-23-049275 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,829

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 9, 2023.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 7,417 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
September 08, 2023 Filed Sep 12, 2023 20:31 UTC
Gardiner WarrenChief Financial Officer
SaleCommon Stock 500 $115.43 $57,715.00
Disclosure

SEC source: 0001209191-23-049112 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,525

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2023.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,960 shares of common stock and 1,345 unvested restricted stock units ("RSUs"), and 4,220 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:47 UTC
Foley DouglasSVP, HR & Administration
SaleCommon Stock 1,600 $113.99 $182,384.00
Disclosure

SEC source: 0001209191-23-047350 · doc4.xml · nonDerivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,402

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 23, 2022.

F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 15,747 shares of common stock and 2,655 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 20:54 UTC SaleCommon Stock 496 $113.56 $56,325.76
Disclosure

SEC source: 0001209191-23-047080 · doc4.xml · nonDerivative · entry 1

Tirinnanzi Martha A · CIK 0001916305 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,878

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 17, 2023.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 842 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
August 16, 2023 Filed Aug 18, 2023 20:49 UTC SaleCommon Stock 496 $113.97 $56,529.12
Disclosure

SEC source: 0001209191-23-046584 · doc4.xml · nonDerivative · entry 1

Tirinnanzi Martha A · CIK 0001916305 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,374

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of May 17, 2023.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 1,338 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
July 12, 2023 Filed Jul 14, 2023 20:49 UTC Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 3,000 $0.00 Strike: $41.37 $0.00
Disclosure

SEC source: 0001209191-23-042274 · doc4.xml · derivative · entry 3

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,100

Underlying: Common Stock · 3,000 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

Read SEC document
July 12, 2023 Filed Jul 14, 2023 20:49 UTC SaleCommon Stock 3,000 $115.54 $346,620.00
Disclosure

SEC source: 0001209191-23-042274 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,647

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 112,373 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
July 12, 2023 Filed Jul 14, 2023 20:49 UTC Exercise / conversionCommon Stock 3,000 $41.37 $124,110.00
Disclosure

SEC source: 0001209191-23-042274 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,647

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.

F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023.

Read SEC document
July 12, 2023 Filed Jul 14, 2023 20:48 UTC
Edmonds Christopher ScottChief Development Officer
SaleCommon Stock 1,044 $115.54 $120,623.76
Disclosure

SEC source: 0001209191-23-042273 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,256

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 9, 2023.

F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,844 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
June 09, 2023 Filed Jun 13, 2023 20:32 UTC
Gardiner WarrenChief Financial Officer
SaleCommon Stock 500 $110.52 $55,260.00
Disclosure

SEC source: 0001209191-23-036713 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,025

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2023.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,460 shares of common stock and 1,345 unvested restricted stock units ("RSUs"), and 4,220 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 20:35 UTC
Martin Lynn CPresident, NYSE Group
GiftCommon Stock 231 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035436 · doc4.xml · nonDerivative · entry 1

Martin Lynn C · CIK 0001754817 · President, NYSE Group

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,172

F1 · shares: This transaction involved a gift of 231 shares of the issuer's common stock by the reporting person to a philanthropic organization.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 37,877 shares of common stock and 2,560 unvested restricted stock units ("RSUs"), and 9,735 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:34 UTC Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 2,000 $0.00 Strike: $41.37 $0.00
Disclosure

SEC source: 0001209191-23-035433 · doc4.xml · derivative · entry 3

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 2,000 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:34 UTC SaleCommon Stock 2,000 $108.50 $217,000.00
Disclosure

SEC source: 0001209191-23-035433 · doc4.xml · nonDerivative · entry 2

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,526

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 112,252 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 20:34 UTC Exercise / conversionCommon Stock 2,000 $41.37 $82,740.00
Disclosure

SEC source: 0001209191-23-035433 · doc4.xml · nonDerivative · entry 1

Jackson Benjamin · CIK 0001722067 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:31 UTC
Edmonds Christopher ScottChief Development Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 4,223 $0.00 Strike: $57.31 $0.00
Disclosure

SEC source: 0001209191-23-034769 · doc4.xml · derivative · entry 3

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 4,223 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:31 UTC
Edmonds Christopher ScottChief Development Officer
SaleCommon Stock 4,223 $108.14 $456,686.20
Disclosure

SEC source: 0001209191-23-034769 · doc4.xml · nonDerivative · entry 2

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,179

F1 · price: The price range for the aggregate amount sold by the direct holder is $108.1200 - $108.1650. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,767 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:31 UTC
Edmonds Christopher ScottChief Development Officer
Exercise / conversionCommon Stock 4,223 $57.31 $242,020.13
Disclosure

SEC source: 0001209191-23-034769 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,402

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 23, 2023 Filed May 23, 2023 20:45 UTC
Foley DouglasSVP, HR & Administration
SaleCommon Stock 1,600 $108.48 $173,568.00
Disclosure

SEC source: 0001209191-23-031682 · doc4.xml · nonDerivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,881

F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 17,226 shares of common stock and 2,655 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
May 23, 2023 Filed May 25, 2023 16:46 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative 70,442 $0.00 Strike: $41.59 $0.00
Disclosure

SEC source: 0001209191-23-032197 · doc4.xml · derivative · entry 7

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,442

Underlying: Common Stock · 70,442 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: These options are fully vested.

Read SEC document
May 23, 2023 Filed May 25, 2023 16:46 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 697 $108.43 $75,574.11
Disclosure

SEC source: 0001209191-23-032197 · doc4.xml · nonDerivative · entry 5

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · CPEX

Disclosed balance after: 2,911,705

F5 · price: The price range for the aggregate amount sold by the direct holder is $108.32 - $108.64. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F6 · balance_after: As previously reported, the reporting person also indirectly owns 2,911,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

Read SEC document
May 23, 2023 Filed May 25, 2023 16:46 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 29,303 $107.88 $3,161,219.36
Disclosure

SEC source: 0001209191-23-032197 · doc4.xml · nonDerivative · entry 4

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · CPEX

Disclosed balance after: 2,912,402

F4 · price: The price range for the aggregate amount sold by the direct holder is $107.32 - $108.31. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2023 Filed May 25, 2023 16:46 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 2,583 $108.41 $280,030.52
Disclosure

SEC source: 0001209191-23-032197 · doc4.xml · nonDerivative · entry 3

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,188,085

F2 · price: The price range for the aggregate amount sold by the direct holder is $108.30 - $108.64. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,146,700 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
May 23, 2023 Filed May 25, 2023 16:46 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
SaleCommon Stock 82,878 $107.87 $8,940,315.07
Disclosure

SEC source: 0001209191-23-032197 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,190,668

F1 · price: The price range for the aggregate amount sold by the direct holder is $107.30 - $108.29. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2023 Filed May 25, 2023 16:46 UTC
Sprecher Jeffrey CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 70,442 $41.59 $2,929,682.78
Disclosure

SEC source: 0001209191-23-032197 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,273,546

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:40 UTC GrantCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031676 · doc4.xml · nonDerivative · entry 1

NOONAN THOMAS E · CIK 0001079742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,507

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 16,471 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:38 UTC GrantCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031673 · doc4.xml · nonDerivative · entry 1

Farooqui Duriya M · CIK 0001699994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,413

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 11,377 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:39 UTC GrantCommon Stock 2,267 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031674 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,251

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,267 restricted stock units awarded, 2,036 were awarded as compensation for service on the Issuer's board and 231 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 15,984 shares of common stock and 2,267 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:42 UTC GrantCommon Stock 2,267 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031678 · doc4.xml · nonDerivative · entry 1

SPRIESER JUDITH A · CIK 0001206994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,831

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,267 restricted stock units awarded, 2,036 were awarded as compensation for service on the Issuer's board and 231 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 31,564 shares of common stock and 2,267 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:39 UTC GrantCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031675 · doc4.xml · nonDerivative · entry 1

Mulhern Mark F · CIK 0001342425 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,498

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 5,462 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

F3 · balance_after: Amount of securities beneficially owned includes 64 shares acquired in a dividend reinvestment transaction.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:44 UTC GrantCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031681 · doc4.xml · nonDerivative · entry 1

Tirinnanzi Martha A · CIK 0001916305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,870

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 1,834 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:41 UTC GrantCommon Stock 2,267 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031677 · doc4.xml · nonDerivative · entry 1

Silver Caroline Louise · CIK 0001821735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,164

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,267 restricted stock units awarded, 2,036 were awarded as compensation for service on the Issuer's board and 231 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Europe Limited.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 5,897 shares of common stock and 2,267 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:37 UTC GrantCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031672 · doc4.xml · nonDerivative · entry 1

Cooper Shantella E. · CIK 0001698291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,434

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 5,398 shares of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 19, 2023 Filed May 23, 2023 20:36 UTC
Bowen SharonDirector
GrantCommon Stock 2,036 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-031671 · doc4.xml · nonDerivative · entry 1

Bowen Sharon · CIK 0001724974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,909

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 12,873 of common stock and 2,036 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 19, 2024.

Read SEC document
May 17, 2023 Filed May 17, 2023 20:35 UTC SaleCommon Stock 150 $107.70 $16,155.00
Disclosure

SEC source: 0001209191-23-030214 · doc4.xml · nonDerivative · entry 1

Tirinnanzi Martha A · CIK 0001916305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,834

Read SEC document
May 15, 2023 Filed May 17, 2023 20:33 UTC Tax withholdingCommon Stock 143 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-030208 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,984

F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:34 UTC Tax withholdingCommon Stock 120 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-030210 · doc4.xml · nonDerivative · entry 1

Silver Caroline Louise · CIK 0001821735 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,897

F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:32 UTC
Edmonds Christopher ScottChief Development Officer
Tax withholdingCommon Stock 463 $109.86 $50,865.18
Disclosure

SEC source: 0001209191-23-030205 · doc4.xml · nonDerivative · entry 2

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,179

F2 · shares: Represents shares of restricted stock issued to the filing person on May 13, 2022. The restricted stock units vest over three years (1/3 on May 13, 2023, 1/3 on May 13, 2024 and 1/3 on May 13, 2025). Of the 3,052 shares, 1,017 shares were issued on May 15, 2023, of which 463 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,035 shares are scheduled to be issued on May 13, 2024 and May 13, 2025 and taxes for these issuances will be withheld and reported at the time of vesting.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,767 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting.

Read SEC document
May 15, 2023 Filed May 17, 2023 20:32 UTC
Edmonds Christopher ScottChief Development Officer
Tax withholdingCommon Stock 402 $109.86 $44,163.72
Disclosure

SEC source: 0001209191-23-030205 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,642

F1 · shares: Represents shares of restricted stock issued to the filing person on May 15, 2020. The restricted stock units vested over three years (1/3 on May 15, 2021, 1/3 on May 15, 2022 and 1/3 on May 15, 2023). Of the 2,674 shares that vested, 892 shares were issued on May 15, 2023, of which 402 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:58 UTC
Gardiner WarrenChief Financial Officer
Tax withholdingCommon Stock 412 $101.51 $41,822.12
Disclosure

SEC source: 0001209191-23-014314 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,525

F1 · shares: Represents shares of restricted stock issued to the filing person on February 26, 2021. The restricted stock units vest over three years (1/3 on February 26, 2022, 1/3 on February 26, 2023 and 1/3 on February 26, 2024). Of the 2,719 shares, 906 shares were issued on February 27, 2023, of which 412 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 907 shares are scheduled to be issued on February 26, 2024 and taxes for this issuance will be withheld and reported at the time of vesting.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,960 shares of common stock and 1,345 unvested restricted stock units ("RSUs"), and 4,220 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting.

F3 · balance_after: In the initial Form 3 filed for the reporting person, the number of unvested RSUs and unvested PSUs were transposed in the footnote describing the components that made up the aggregate beneficial ownership amount. At the time of filing the Form 3, the reporting person held 5,370 unvested RSUs instead of 4,680 unvested RSUs and held 4,680 unvested PSUs instead of 5,370 unvested PSUs. The aggregate amount of securities beneficially owned by the reporting person reported in the Form 3 and reported in each Form 4 since the filing of the Form 3, does accurately reflect the amount of securities beneficially owned by the reporting person at that time and only the footnote displays the transposed amounts for the unvested RSUs and unvested PSUs. Footnote 2 above, reflects changes to the number of unvested RSUs and unvested PSUs held by the reporting person to show the correct amount in the footnote currently held for each type as of the date of this filing.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.